Article Type
Changed
Fri, 01/18/2019 - 08:38
Display Headline
Vaccine prevents genital herpes in subgroup of women
PRACTICE RECOMMENDATIONS

The herpes simplex virus (HSV) type-2 vaccine studied here prevented genital herpes only in women who were seronegative for HSV-1 and HSV-2 at baseline. Ten of these women would need to be vaccinated to prevent 1 case of genital herpes. The vaccine did not prevent infection with HSV-2 in these women. It did not prevent genital herpes in women with other HSV serologic status or in men.

The usefulness of this vaccine is limited by the small subgroup in which it is efficacious. Determining which women fall into this subgroup could prove costly. It is possible that asymptomatic infected persons may spread HSV more readily. Emphasis on the use of condoms and antiviral agents should still be the first line in preventing the spread of genital herpes.

 
Article PDF
Author and Disclosure Information

Practice Recommendations from Key Studies

Stanberry LR, Spruance SL, Cunningham AL, et al. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 2002; 347:1652–61.

Charles Cole, MD
Department of Family Medicine, University of Virginia, Stoney Creek Family Practice, Nellysford, Va

[email protected]

Issue
The Journal of Family Practice - 52(2)
Publications
Topics
Page Number
94-117
Sections
Author and Disclosure Information

Practice Recommendations from Key Studies

Stanberry LR, Spruance SL, Cunningham AL, et al. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 2002; 347:1652–61.

Charles Cole, MD
Department of Family Medicine, University of Virginia, Stoney Creek Family Practice, Nellysford, Va

[email protected]

Author and Disclosure Information

Practice Recommendations from Key Studies

Stanberry LR, Spruance SL, Cunningham AL, et al. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 2002; 347:1652–61.

Charles Cole, MD
Department of Family Medicine, University of Virginia, Stoney Creek Family Practice, Nellysford, Va

[email protected]

Article PDF
Article PDF
PRACTICE RECOMMENDATIONS

The herpes simplex virus (HSV) type-2 vaccine studied here prevented genital herpes only in women who were seronegative for HSV-1 and HSV-2 at baseline. Ten of these women would need to be vaccinated to prevent 1 case of genital herpes. The vaccine did not prevent infection with HSV-2 in these women. It did not prevent genital herpes in women with other HSV serologic status or in men.

The usefulness of this vaccine is limited by the small subgroup in which it is efficacious. Determining which women fall into this subgroup could prove costly. It is possible that asymptomatic infected persons may spread HSV more readily. Emphasis on the use of condoms and antiviral agents should still be the first line in preventing the spread of genital herpes.

 
PRACTICE RECOMMENDATIONS

The herpes simplex virus (HSV) type-2 vaccine studied here prevented genital herpes only in women who were seronegative for HSV-1 and HSV-2 at baseline. Ten of these women would need to be vaccinated to prevent 1 case of genital herpes. The vaccine did not prevent infection with HSV-2 in these women. It did not prevent genital herpes in women with other HSV serologic status or in men.

The usefulness of this vaccine is limited by the small subgroup in which it is efficacious. Determining which women fall into this subgroup could prove costly. It is possible that asymptomatic infected persons may spread HSV more readily. Emphasis on the use of condoms and antiviral agents should still be the first line in preventing the spread of genital herpes.

 
Issue
The Journal of Family Practice - 52(2)
Issue
The Journal of Family Practice - 52(2)
Page Number
94-117
Page Number
94-117
Publications
Publications
Topics
Article Type
Display Headline
Vaccine prevents genital herpes in subgroup of women
Display Headline
Vaccine prevents genital herpes in subgroup of women
Sections
Disallow All Ads
Article PDF Media